Cilnidipine-Induced Spontaneous Hypoglycemia in a Young Female: A Case Report

Cilnidipine is a calcium channel blocker and used as a latest antihypertensive agent. Incidences of adverse drug event with the molecules of this class of antihypertensive agents among the hospitalized patients are common but such an event with cilnidipine is rare. Here, we present a case on a 27-year old non-diabetic female patient who developed spontaneous hypoglycemia after administering cilnidipine orally to manage her high blood pressure. When the adverse drug event was identified, the cilnidipine therapy was stopped and patient recovered from hypoglycemia. No further incidence of hypoglycemia happened during her hospitalization time.